The trademark NEUROVERT was filed by SUN WAVE PHARMA INTERNATIONAL LIMITED, a corporation established under the laws of the Republic of Cyprus (the "Applicant"). The application was published for oppositions on March 10, 2022, and received one opposition filed on May 8, 2022 by Rubimed AG on Likelihood of confusion. the opponent was represented by MANITZ FINSTERWALD PATENT- UND RECHTSANWALTSPARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 8, 2022
The application was filed in Romanian, and Romanian was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003170670 was rejected according to Article 8(1)(b) EUTMR with decision issued on June 20, 2024 by the EUIPO. The Appeal with reference B R1638/2024-5 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on January 22, 2025 by the EUIPO.